Evaluación del seguimiento de niños con hallazgo de hipertransaminasemia
Fernández Ventureira, V. ; Ros Arnal, I. ; Rodríguez Martínez, G. (Universidad de Zaragoza) ; García Rodríguez, B. ; García Romero, R. ; Ubalde Sainz, E.
Resumen: Introduction: Although changes in liver function tests can be non-specific in numerous clinical conditions, they can be the first sign of a potentially serious disease in an asymptomatic patient.
Material and methods: Retrospective cohort study, performed by reviewing the records of children of a reference hospital central laboratory with alanine aminorransferase enzyme (ALT) elevation during a 6 month aleatory period.
Results: 572 blood tests with serum ALT elevation corresponding to 403 patients had been assessed during the period studied. 98 patients were excluded for presenting abnormal liver test before the study period of comorbidity that could produce ALT elevation. The remaining 305 patients, 22.6% were diagnosed with a medical condition during the first blood test that explained the ALT elevation, although only 33.3% of them were followed up until verifying their normalization. Final study sample consists of 236 patients with abnormal liver test without apparent liver disease. Adequate follow-up was found only in 29% of them. From this group, 9 patients (13%) were diagnosed with liver disease. The rest of the sample were not properly monitored. In patients with higher serum ALT levels, follow-up was early and more appropiate.
Conclusions: In our area, most children without apparent liver disease are no properly monitored. Therefore, an opportunity to diagnosis and treat a potential liver disease was lost in a great number of children. All children with unexplainedhypertransaminasaemia must be studied.
Idioma: Español
DOI: 10.1016/j.anpedi.2020.06.019
Año: 2021
Publicado en: Anales de Pediatria 94, 6 (2021), 359-365
ISSN: 1695-4033
Factor impacto JCR: 2.377 (2021)
Categ. JCR: PEDIATRICS rank: 77 / 130 = 0.592 (2021) - Q3 - T2
Factor impacto CITESCORE: 1.8 - Medicine (Q3)
Factor impacto SCIMAGO: 0.312 - Pediatrics, Perinatology and Child Health (Q3)
Tipo y forma: Artículo (Versión definitiva)
Área (Departamento): Área Pediatría (Dpto. Microb.Ped.Radio.Sal.Pú.)
Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace. No puede utilizar el material para una finalidad comercial. Si remezcla, transforma o crea a partir del material, no puede difundir el material modificado.
Exportado de SIDERAL (2023-05-18-13:21:05)
Visitas y descargas
Material and methods: Retrospective cohort study, performed by reviewing the records of children of a reference hospital central laboratory with alanine aminorransferase enzyme (ALT) elevation during a 6 month aleatory period.
Results: 572 blood tests with serum ALT elevation corresponding to 403 patients had been assessed during the period studied. 98 patients were excluded for presenting abnormal liver test before the study period of comorbidity that could produce ALT elevation. The remaining 305 patients, 22.6% were diagnosed with a medical condition during the first blood test that explained the ALT elevation, although only 33.3% of them were followed up until verifying their normalization. Final study sample consists of 236 patients with abnormal liver test without apparent liver disease. Adequate follow-up was found only in 29% of them. From this group, 9 patients (13%) were diagnosed with liver disease. The rest of the sample were not properly monitored. In patients with higher serum ALT levels, follow-up was early and more appropiate.
Conclusions: In our area, most children without apparent liver disease are no properly monitored. Therefore, an opportunity to diagnosis and treat a potential liver disease was lost in a great number of children. All children with unexplainedhypertransaminasaemia must be studied.
Idioma: Español
DOI: 10.1016/j.anpedi.2020.06.019
Año: 2021
Publicado en: Anales de Pediatria 94, 6 (2021), 359-365
ISSN: 1695-4033
Factor impacto JCR: 2.377 (2021)
Categ. JCR: PEDIATRICS rank: 77 / 130 = 0.592 (2021) - Q3 - T2
Factor impacto CITESCORE: 1.8 - Medicine (Q3)
Factor impacto SCIMAGO: 0.312 - Pediatrics, Perinatology and Child Health (Q3)
Tipo y forma: Artículo (Versión definitiva)
Área (Departamento): Área Pediatría (Dpto. Microb.Ped.Radio.Sal.Pú.)
Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace. No puede utilizar el material para una finalidad comercial. Si remezcla, transforma o crea a partir del material, no puede difundir el material modificado.Exportado de SIDERAL (2023-05-18-13:21:05)
Enlace permanente:
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
Artículos
Registro creado el 2020-12-04, última modificación el 2023-05-19